The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $62.63

Today's change-0.31 -0.49%
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $62.63

Today's change-0.31 -0.49%
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.

Merck & Co Inc crosses below 200-day moving average

Merck & Co Inc closed lower Friday, dropping (U.S.)$0.31 or 0.49% to (U.S.)$62.63 and crossing below its 200-day moving average. Shares have lost 0.68% over the last five days, but have gained 6.39% over the last year to date. This security has underperformed the S&P 500 by 7.66% during the last year.

Key company metrics

  • Open(U.S.) $62.79
  • Previous close(U.S.) $62.94
  • High(U.S.) $63.00
  • Low(U.S.) $62.58
  • Bid / Ask-- / --
  • YTD % change+6.39%
  • Volume6,906,447
  • Average volume (10-day)6,784,873
  • Average volume (1-month)8,951,656
  • Average volume (3-month)8,760,818
  • 52-week range(U.S.) $57.18 to (U.S.) $66.80
  • Beta0.81
  • Trailing P/E40.12×
  • P/E 1 year forward16.26×
  • Forward PEG2.76×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield3.00%
  • Trailing EPS(U.S.) $1.56
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.53%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue9,43410,11510,5369,844
Total other revenue--------
Total revenue9,43410,11510,5369,844
Gross profit7,3317,6157,9357,427
Total cost of revenue2,1032,5002,6012,417
Total operating expense7,37311,4647,6258,206
Selling / general / administrative2,4112,5642,3562,353
Research & development1,7961,2651,6451,892
Depreciation / amortization7738007721,000
Interest expense (income), net operating--------
Unusual expense (income)2904,335251544
Other operating expenses, total--------
Operating income2,061-1,3492,9111,638
Interest income (expense), net non-operating-182-180-170-171
Gain (loss) on sale of assets--------
Other--------
Income before tax2,003-1,3562,8871,504
Income after tax1,556-5872,1881,209
Income tax, total447-769699295
Net income1,551-5952,1841,205
Total adjustments to net income--------
Net income before extra. items1,551-5952,1841,205
Minority interest-5-8-4-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,551-5952,1841,205
Inc. avail. to common incl. extra. items1,551-5952,1841,205
Diluted net income1,551-5952,1841,205
Dilution adjustment--------
Diluted weighted average shares2,7662,7572,7862,789
Diluted EPS excluding extraordinary itemsvalue per share0.56-0.220.780.43
Dividends per sharevalue per share0.470.460.460.46
Diluted normalized EPSvalue per share0.642.421.421.22